Author

Indu Javeri

CuriRx (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Bijay MisraiD· 1 shared Kaliappanadar NellaiappaniD· 1 shared Robert H. ShoemakeriD· 1 shared Shanker L. GuptaiD· 1 shared TIMOTHY R. FOUTSiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Bijay MisraORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Development of a Stable Lyophilized Formulation of a Quadrivalent Frame-Shift Peptide Vaccine for Cancer Prevention in Lynch Syndrome

Shanker L. Gupta, Bijay Misra, Indu Javeri, Kaliappanadar Nellaiappan, TIMOTHY R. FOUTS, Robert H. Shoemaker

The paper develops a stable lyophilized formulation for a quadrivalent frame-shift peptide vaccine targeting Lynch syndrome-associated cancers, showing stability for 18 months at ambient temperatures.

bioRxiv · Aug 14, 2025 · PreprintPharmacology & Toxicology